The natural history of HIV infection has been irrefutably altered by the introduction of combination antiretroviral therapy during the latter half of the 1990s.[@ref1]^,^[@ref2] Most notably, between 1995 and 2009, an estimated 14.4 million life-years were gained globally among HIV-infected adults who received this form of therapy.[@ref3] In conjunction with this achievement, the epidemiology of HIV infection has changed markedly since the earliest years of the epidemic, such that greater demographic diversity among persons with a diagnosis of HIV has been described internationally.[@ref4]^,^[@ref5] In this context, accurate population-based estimates of the incidence and prevalence of persons with HIV who are entering care are needed to optimize health service delivery and to improve the health outcomes of these individuals.

In Ontario, epidemiologic surveillance of HIV infection is conducted by the Ontario HIV Epidemiologic Monitoring Unit. This agency publishes annual surveillance reports characterizing trends in the epidemic based on data from various sources, including the public health laboratory system of Public Health Ontario, which performs almost all HIV diagnostic testing in the province.[@ref6] However, these data do not provide insight into the characteristics of individuals with HIV who have accessed the health care system. Consequently, existing methods of population-based HIV surveillance are not conducive to the study of longitudinal trends in rates of comorbid illness, entry to and retention in care, and demographic characteristics of persons with physician-diagnosed HIV. In contrast, administrative health care databases provide a means for conducting longitudinal population-based research of all persons living with HIV who have entered care. Although these databases have been used for the surveillance of various chronic diseases,[@ref7]^--^[@ref11] there have been, to our knowledge, no studies describing the use of these databases to characterize trends in the epidemiology and outcomes of persons living with HIV within a large geographic region. Accordingly, we used administrative health care databases to assemble a population-based cohort of all adults with HIV who have entered care in Ontario and used these data to quantify trends in rates of HIV prevalence, new HIV diagnoses, and mortality among adults with HIV in Ontario from fiscal year 1996/1997 to fiscal year 2009/2010.

Methods {#S1}
=======

Data sources. {#S1a}
-------------

We obtained data from Ontario\'s administrative health care databases, which are available at the Institute for Clinical Evaluative Sciences through a data-sharing agreement with the Ontario Ministry of Health and Long-Term Care. Specifically, we used the Ontario Health Insurance Plan (OHIP) database to identify physician claims for HIV-related visits and obtained socio-demographic and date-of-death information from the Registered Persons Database, a registry of all Ontario residents eligible for health insurance. We used validated disease registries maintained by the Institute for Clinical Evaluative Sciences to identify comorbid conditions in persons with HIV.[@ref12]^--^[@ref15] These databases, which are routinely used for population-based chronic disease surveillance,[@ref7]^--^[@ref11] were linked in an anonymous fashion using encrypted health card numbers.

Study population. {#S1b}
-----------------

We used a case-finding algorithm that had been validated with the charts of patients from 2 primary care clinics[@ref16] to generate a database of individuals in Ontario aged 18 years or older who were living with HIV and who had entered care between 1 April 1996, and 31 March 2010. Briefly, an algorithm based on a minimum of 3 physician claims with an International Classification of Diseases, Ninth Revision code for HIV infection (i.e., code 042, 043, or 044) within a 3-year period achieved sensitivity of 96.2% (95% confidence interval \[CI\] 95.2% to 97.9%) and specificity of 99.6% (95% CI 99.1% to 99.8%) for identification of patients who were regular users of primary care.[@ref16] We chose the end of fiscal year 2009/2010 as the end point for our analyses to meet the 3-year look-forward criterion of the algorithm. Because HIV is incurable, individuals who met the case definition for HIV infection remained part of the cohort throughout the study period, unless they died or moved out of the province of Ontario.

Outcomes. {#S1c}
---------

The primary outcomes of the study were age- and sex-standardized prevalence of HIV infection and rates of new HIV diagnoses per 100 000 population of Ontario for each fiscal year between 1996/1997 and 2009/2010, and yearly all-cause mortality rate per 100 adults with HIV over the same period. We calculated these rates by direct standardization using the 1991 Ontario population as the reference population. We determined the annual prevalence of HIV infection by dividing the number of adults with HIV who had entered care and who were alive at the end of each fiscal year by the census population of Ontario aged 18 years and older for the corresponding year. We classified patients as being newly diagnosed according to the date on which they first entered care (i.e., the date of their first claim for an HIV-related visit) and calculated rates of new diagnoses of HIV infection by dividing the number of new diagnoses by the number of individuals aged 18 or older at risk for the disease that year (the total population minus the number of people with prevalent HIV in the previous year). To distinguish between a new diagnosis and a prevalent case, we required that individuals have no prior physician claims for HIVrelated visits in the 5 years preceding their diagnosis date. Individuals who had a claim during this window were counted as prevalent cases rather than new diagnoses. Because the OHIP database does not include claims before 1991, we chose to start reporting results with fiscal year 1996/1997 to allow for this 5-year lookback period. We estimated the annual rate of all-cause mortality among adults with HIV who had entered care by dividing the annual number of deaths among these individuals by the number of adults with HIV in each year. We report annual rates of all-cause mortality because information on disease-specific mortality was unavailable in our databases.

Statistical analysis. {#S1d}
---------------------

We used negative binomial regression analysis to examine temporal trends in prevalence of HIV, rates of new HIV diagnoses, and mortality rates, using the population denominators as the offset. All models included year as the main predictor, along with variables for age group (18--34 years, 36--49 years, and ≥ 50 years) and sex. Because of statistically significant (*p* \< 0.001) 3-way interactions between age group, sex, and year in all models, we stratified the regression analyses by age group and sex. Therefore, for each age-- sex stratum, the following model was fit:
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where exp(β0) is the outcome rate in the reference year (1996/1997) and 100 × \[exp(β1) -- 1\] is the percent relative annual change in the outcome averaged over the 14-year study period.

All statistical analyses were conducted using SAS version 9.2 (SAS institute, Cary, NC).

Ethics approval. {#S1e}
----------------

We obtained ethics approval for this study from the Research Ethics Board of Sunnybrook Health Sciences Centre.

Results {#S2}
=======

Between 1996/1997 and 2009/2010, the number of adults living with HIV infection increased by 98.6% (from 7608 to 15 107), which far outpaced the 23.3% relative increase in the adult population of Ontario during this period. Women accounted for an increasing proportion of all adults with HIV during the study period, from 12.8% in 1996/1997 to 19.7% in 2009/2010 (*p* \< 0.001) ([Table 1](#T1){ref-type="table"}). Similarly, the proportion of persons with HIV who were 50 years of age or older increased from 10.4% to 29.9% over the study period (*p* \< 0.001) ([Table 1](#T1){ref-type="table"}). In 2009/2010, the majority of people with HIV aged 50 years or older were men (3847 of 4520 \[85.1%\]). Women and individuals 50 years of age or older were also increasingly represented among those with new HIV diagnoses, increasing from 15.4% (153 of 994) to 24.7% (198 of 802) (*p* \< 0.001) and from 10.7% (106 of 994) to 15.6% (125 of 802) (*p* = 0.002), respectively, between 1996/1997 and 2009/2010. The prevalence of selected comorbid conditions associated with aging also increased over time ([Table 1](#T1){ref-type="table"}).

###### 

Characteristics of Ontario adults living with HIV who have entered care

  Characteristic             Fiscal year; no. (%) of individuals   *p* value                       
  -------------------------- ------------------------------------- --------------- --------------- ----------
  **Age, yr**                                                                                      \< 0.001
  18--35                     3 713 (48.8)                          2 973 (27.4)    2 695 (17.8)    
  36--49                     3 101 (40.8)                          5 902 (54.4)    7 892 (52.2)    
  ≥ 50                       794 (10.4)                            1 975 (18.2)    4 520 (29.9)    
  **Sex**                                                                                          \< 0.001
  Female                     971 (12.8)                            1 781 (16.4)    2 974 (19.7)    
  Male                       6 637 (87.2)                          9 069 (83.6)    12 133 (80.3)   
  **Urban residence**        7 353 (96.6)                          10 401 (95.9)   14 500 (96.0)   0.02
  **Comorbidity**                                                                                  
  Diabetes mellitus          213 (2.8)                             563 (5.2)       1 313 (8.7)     \< 0.001
  COPD                       293 (3.9)                             588 (5.4)       1 171 (7.8)     \< 0.001
  Congestive heart failure   53 (0.7)                              133 (1.2)       284 (1.9)       \< 0.001
  Hypertension               456 (6.0)                             1 142 (10.5)    2 398 (15.9)    \< 0.001
  Myocardial infarction      28 (0.4)                              96 (0.9)        200 (1.3)       \< 0.001

COPD = chronic obstructive pulmonary disease.

Prevalence. {#S2a}
-----------

The age- and sex-standardized prevalence of HIV per 100 000 population increased from 92.8 (95% CI 90.7 to 94.9) in 1996/1997 to 141.8 (95% CI 139.5 to 144.1) in 2009/2010, a relative increase of 52.8% (*p* \< 0.001) ([Table 2](#T2){ref-type="table"}). The age-standardized increase in HIV prevalence was greater among women than men ([Figure 1A](#F1){ref-type="fig"}), and the sex-standardized prevalence increased with age ([Figure 1B](#F1){ref-type="fig"}). The prevalence of HIV increased in all age strata of women over the study period, with the average increase ranging from 3.2% (95% CI 2.5% to 4.0%) per year among women aged 18 to 35 years to 11.3% (95% CI 10.4% to 12.2%) per year among women aged 50 years or older ([Table 3](#T3){ref-type="table"}). Among men aged 18 to 35 years, the prevalence of HIV decreased between 1996/1997 and 2009/2010, with a mean annual change of --5.3% (95% CI --6.0% to --4.7%). In contrast, the prevalence of HIV increased in the other age strata of men, the most notable change being observed for the group 50 years of age or older (10.6%, 95% CI 10.0% to 11.1%) ([Table 3](#T3){ref-type="table"}).

![Trends in HIV prevalence.\
(A) Age-standardized trends, by sex.\
(B) Sex-standardized trends, by age group.](OpenMed-07-98-g001){#F1}

###### 

Age- and sex-standardized HIV prevalence, new diagnosis rate, and all-cause mortality rate among Ontario adults [\*](#T2FN1){ref-type="table-fn"} who entered care, 1996/1997 to 2009/2010

  Fiscal year   Prevalence of HIV   New diagnoses of HIV   Deaths from any cause                             
  ------------- ------------------- ---------------------- ----------------------- ------------------- ----- ----------------
  1996/1997     7 608               92.8 (90.7--94.9)      994                     12.3 (11.5--13.1)   447   5.7 (4.6--6.9)
  1997/1998     8 079               97.1 (94.9--99.2)      926                     11.3 (10.6--12.1)   244   4.4 (3.3--5.7)
  1998/1999     8 622               101.9 (99.8--104.1)    803                     9.7 (9.1--10.4)     194   3.2 (2.3--4.4)
  1999/2000     9 193               106.4 (104.2--108.6)   762                     9.0 (8.4--9.7)      224   2.8 (2.1--3.8)
  2000/2001     9 712               109.1 (106.9--111.3)   781                     9.1 (8.5--9.8)      212   3.0 (2.2--4.0)
  2001/2002     10 228              111.2 (109.1--113.4)   744                     8.6 (7.9--9.2)      189   2.6 (1.9--3.4)
  2002/2003     10 850              114.6 (112.5--116.8)   836                     9.4 (8.8--10.1)     209   2.7 (2.0--3.6)
  2003/2004     11 439              118.1 (115.9--120.3)   812                     9.0 (8.3--9.6)      182   2.5 (1.8--3.3)
  2004/2005     12 072              122.2 (120.0--124.4)   848                     9.3 (8.7--10.0)     196   2.0 (1.5--2.6)
  2005/2006     12 702              126.3 (124.1--128.6)   863                     9.4 (8.8--10.0)     209   1.9 (1.5--2.5)
  2006/2007     13 319              130.5 (128.3--132.8)   838                     9.1 (8.5--9.7)      199   1.7 (1.3--2.1)
  2007/2008     13 893              134.0 (131.7--136.2)   820                     8.6 (8.0--9.2)      210   1.9 (1.4--2.4)
  2008/2009     14 516              138.0 (135.8--140.3)   835                     8.7 (8.1--9.3)      214   2.1 (1.7--2.7)
  2009/2010     15 107              141.8 (139.5--144.1)   802                     8.3 (7.8--8.9)      228   1.6 (1.3--2.0)

Age 18 years or older.

Age- and sex-standardized.

###### 

Age- and sex-specific prevalence of adults with HIV who entered care in Ontario

  Sex and age   Fiscal year; crude prevalence per 100 000 population   \% relative annual change (95% CI)            
  ------------- ------------------------------------------------------ ------------------------------------ -------- ------------------------
  **Female**                                                                                                         
  18--35 yr     37.37                                                  51.48                                55.47    3.2 (2.5 to 4.0)
  36--49 yr     23.69                                                  52.65                                99.53    11.0 (10.2 to 11.8)
  ≥ 50 yr       7.29                                                   14.88                                29.63    11.3 (10.4 to 12.2)
  **Male**                                                                                                           
  18--35 yr     205.09                                                 144.12                               112.38   --5.3 (--6.0 to --4.7)
  36--49 yr     234.60                                                 369.97                               455.75   5.2 (4.4 to 6.0)
  ≥ 50 yr       50.40                                                  105.04                               191.10   10.6 (10.0 to 11.1)

CI = confidence interval.

New HIV diagnoses. {#S2b}
------------------

The age- and sex-standardized rate of new HIV diagnoses per 100 000 population declined from 12.3 (95% CI 11.5 to 13.1) in 1996/1997 to 8.3 (95% CI 7.8 to 8.9) in 2009/2010, a relative decrease of 32.5% (*p* \< 0.001) ([Table 2](#T2){ref-type="table"}). However, despite this decline, the annual number of new HIV diagnoses was relatively stable between 2002/2003 and 2009/2010, ranging from 802 to 863 cases during this period. The agestandardized rate of new diagnoses decreased among men ([Figure 2A](#F2){ref-type="fig"}), and overall sex-standardized rates declined in all age strata, most notably among individuals in the 18- to 35-year and 36- to 49-year strata ([Figure 2B](#F2){ref-type="fig"}). In contrast to the situation for men, the annual rate of new HIV diagnoses increased among women 36 to 49 years of age (3.2%, 95% CI 1.0% to 5.4%) and those 50 years of age or older (5.0%, 95% CI 2.2% to 8.0%) ([Table 4](#T4){ref-type="table"}).

![Trends in rates of new diagnosis.\
(A) Age-standardized trends, by sex.\
(B) Sex-standardized trends, by age group.](OpenMed-07-98-g002){#F2}

###### 

Age- and sex-specific rates of new HIV diagnoses among adults who entered care in Ontario

  Sex and age   Fiscal year; crude rate of new diagnosis per 100 000 population   \% relative annual change (95% CI)           
  ------------- ----------------------------------------------------------------- ------------------------------------ ------- ------------------------
  **Female**                                                                                                                   
  18--35 yr     6.47                                                              6.95                                 5.48    --0.3 (--2.0 to 1.5)
  36--49 yr     2.78                                                              3.43                                 5.22    3.2 (1.0 to 5.4)
  ≥ 50 yr       1.33                                                              1.35                                 1.58    5.0 (2.2 to 8.0)
  **Male**                                                                                                                     
  18--35 yr     30.17                                                             18.32                                14.44   --4.3 (--5.8 to --2.8)
  36--49 yr     24.45                                                             22.63                                19.90   --1.1 (--2.0 to --0.2)
  ≥ 50 yr       6.31                                                              3.89                                 4.42    --0.3 (--2.4 to 1.7)

CI = confidence interval.

All-cause mortality. {#S2c}
--------------------

The overall age- and sex-standardized all-cause mortality rate per 100 adults with HIV declined from 5.7 (95% CI 4.6 to 6.9) in 1996/1997 to 1.6 (1.3 to 2.0) in 2009/2010, which represented a 71.9% relative decrease over this period (*p* \< 0.001) ([Table 2](#T2){ref-type="table"}). All-cause mortality declined in all age strata of both men and women ([Table 5](#T5){ref-type="table"}, [Figures 3A, 3B](#F3){ref-type="fig"}), although rates remained higher among individuals 50 years of age or older relative to younger people ([Table 5](#T5){ref-type="table"}, [Figure 3B](#F3){ref-type="fig"}).

![Trends in deaths of adults with HIV.\
(A) Age-standardized trends, by sex.\
(B) Sex-standardized trends, by age group.](OpenMed-07-98-g003){#F3}

###### 

Age- and sex-specific all-cause mortality rates among adults living with HIV who entered care in Ontario

  Sex and age   Fiscal year; crude mortality rate per 100 adults with HIV   \% relative annual change (95% CI)          
  ------------- ----------------------------------------------------------- ------------------------------------ ------ ---------------------------
  **Female**                                                                                                            
  18--35 yr     3.18                                                        0.65                                 0.22   --14.2 (--18.6 to --9.5)
  36--49 yr     3.79                                                        1.63                                 1.42   --7.7 (--10.9 to --4.3)
  ≥ 50 yr       6.09                                                        4.35                                 2.53   --4.7 (--8.4 to --0.8)
  **Male**                                                                                                              
  18--35 yr     4.26                                                        1.36                                 0.44   --13.8 (--17.0 to --10.6)
  36--49 yr     7.40                                                        1.74                                 1.19   --10.6 (--13.4 to --7.8)
  ≥ 50 yr       10.16                                                       3.55                                 2.70   --7.9 (--10.2 to --5.5)

CI = confidence interval.

Interpretation {#S3}
==============

In our population-based study, the number of adults with HIV increased by 98.6% between 1996/1997 and 2009/2010. This increase is most likely attributable to the striking reduction in all-cause mortality rates observed among these individuals during this period and the essentially stable number of new HIV diagnoses in the last decade of the period. Importantly, however, women and adults aged 50 years or older accounted for increasing proportions of new HIV diagnoses over the study period. Finally, we observed a steady increase in the prevalence of selected comorbid conditions among adults with HIV who had entered care, which reflects the transformation of HIV infection into a complex chronic disease affecting an aging cohort of patients expected to be increasingly burdened by multiple coexisting illnesses.

Our findings have important implications for HIV prevention and public health. The data suggest that the increased relative burden of HIV among women and older individuals may be mostly due to the decreased rate of new diagnoses among younger men, which perhaps reflects the differential emphasis or success of HIV prevention efforts. Older adults in particular have not been routinely targeted by public health interventions to prevent HIV infection, despite a general lack of knowledge about the disease, as well as evidence of HIV risk behaviour, among these individuals.[@ref17]^--^[@ref19] In addition, the absolute number of new HIV diagnoses remained relatively stable in Ontario over the last decade of the study period. Rates of new HIV infections in British Columbia, Ontario, and Quebec have been shown to decline 8% for each 10% increment in coverage for antiretroviral treatment,[@ref20] so universal coverage for these drugs might be useful to augment existing prevention programs in Ontario. Finally, the Ontario HIV Epidemiologic Monitoring Unit estimated that 27 420 Ontarians had had a positive test result for HIV and were alive as of 2009, of whom 17 818 were estimated to be aware of their diagnosis and could therefore presumably generate physician claims for HIV-related visits that would be captured in administrative health care databases.[@ref6] These estimates were based on epidemiologic models derived using data from sources different from the ones used for the current study, including the Public Health Laboratory and the Ontario Registrar General. Using administrative health care databases, we identified 15 107 individuals who met our case-finding definition for HIV infection and who were alive as of fiscal year 2009/2010. Although both approaches to estimating the burden of HIV infection in Ontario have their respective merits and limitations, a key interpretation of both data sets is that a significant proportion of individuals with HIV appear to be unaware of their infection or appear not to be retained in care once a diagnosis has been made and hence did not generate enough claims to be detected by our algorithm. Because these individuals may unknowingly contribute to the annual incidence of new infections and are unable to benefit from HIV-specific care, innovative interventions are required to increase the proportion of persons infected with HIV whose condition is diagnosed and who are retained in care.[@ref21]

Our work had several limitations that merit emphasis. First, administrative health care databases can identify only individuals with physician-diagnosed HIV who are in care; they will not capture people with HIV who are unaware of their diagnosis or individuals who are aware of their diagnosis but have not entered care. Furthermore, we could not identify individuals who obtained care from physicians who do not bill OHIP and/ or were ineligible for provincial public health insurance (e.g., refugee claimants). Our findings therefore underestimate the true incidence and prevalence of HIV in Ontario. In addition, we had no access to patients\' clinical data or information regarding method of HIV acquisition, which rendered it impossible to examine epidemiologic trends in relation to risk factors for HIV infection, stage of illness at the time of diagnosis, or country of birth. However, these limitations are common to all studies that use administrative data for chronic disease surveillance and must be balanced against the strengths of using these data for this purpose, including the identification of all patients who are in care within a geographically large jurisdiction, complete follow-up of these patients over time, and the potential for linkage with other health care data sets.[@ref12]^--^[@ref15] Finally, the potential for misclassification is always a consideration when using administrative data for health services research. To address this concern, we assembled our cohort using a validated algorithm with excellent test characteristics for discriminating between HIV-infected and non-infected individuals.[@ref16] To our knowledge, this is the first population-based study using a validated case-finding algorithm and administrative data to examine trends in the epidemiology of persons with HIV who have entered care.

In summary, we assembled a population-based cohort of adults with HIV who had entered care and then examined trends in HIV prevalence, new HIV diagnoses, and mortality over a 14-year period. Our findings suggest that if current trends continue, it will be necessary to adapt HIV-related health and support services to the needs of an aging cohort of patients with multiple comorbidities who may inevitably require the expertise of sectors of the health care system that have not traditionally been involved in the provision of HIVrelated care, such as gerontology and long-term care. In addition, a large proportion of HIV-infected persons in Ontario are not receiving HIV-related care. Future research examining patterns of and disparities in health services utilization, entry to and retention in care, and trends in the prevalence of comorbid conditions will be required to ensure that HIV-related services continue to evolve in a manner that anticipates the needs of the growing population of persons with HIV.
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